Research and Development

Showing 15 posts of 9603 posts found.

Lixisenatide scores in phase III trial

April 15, 2010 Research and Development GLP-1, Lixisenatide, diabetes

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …

Roche buys insulin patch company

April 13, 2010 Research and Development Diagnostics, Roche, diabetes

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …
AquapharmSimonBest

Dr Simon Best joins Aquapharm as chief executive

April 13, 2010 Research and Development Aquapharm, Aquapharm Biodiscovery, appointment, research and development

Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …

Parexel launches software for post-approval trials

April 12, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel has launched a new web-based technology platform for late phase clinical research that it says makes …

Contract research news in brief

April 12, 2010 Research and Development Ingenix, Medpace, NIB, NexMed, RDNIB

A round-up of recent developments in the clinical research arena includes an expansion for NexMed’s pre-clinical division, acquisitions for Medpace …

Italy’s new R&D centre launched by Burns

April 9, 2010 Research and Development Italy

The recently retired head of Roche’s pharma division has called for more public-private partnerships in the pharma industry. William Burns …

Sanofi-Aventis signs drug with potential to reverse diabetes

April 9, 2010 Research and Development Sanofi, diabetes

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …

ICON and Tigermed forge China alliance

April 7, 2010 Research and Development CRO, China, ICON

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
RochePitzer

Frank Pitzer made chief executive at NimbleGen

April 7, 2010 Research and Development NimbleGen, Roche, appointment, research and development

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …

Talking Point: Responding to Trial Emergencies

April 6, 2010 Research and Development

Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …
retacrit

Biosimilars: the great balancing act

April 6, 2010 Research and Development biogenerics, biosimilars

Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
SirJamesBlack

Obituary: Sir James Black

April 6, 2010 Research and Development appointment, research and development

Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …
Pfizer payments

Pfizer first to disclose trial payments

April 1, 2010 Research and Development, Sales and Marketing Pfizer, industry reputation, payments

Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …

New CRO Celerion rises out of MDS divestment

April 1, 2010 Research and Development Celerion, mds

Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …

Chiltern Announces Investment in Endpoint

April 1, 2010 Research and Development

Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to invest in Endpoint is representative of our commitment to seek collaborations which …
The Gateway to Local Adoption Series

Latest content